Slezavit as a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma. Eura. Med.Res. Per. 2022;9:93-95. Accessed June 18, 2026. https://mail.geniusjournals.org/index.php/emrp/article/view/1726